Skip to main content Skip to footer

Orexo press releases

OX-MPI project returned to Orexo

6 August 2014 at 08:30 – Regulatory

OX-MPI project returned to Orexo

Number of shares and votes in Orexo

31 July 2014 at 17:30 – Regulatory

Number of shares and votes in Orexo

Interim report January-June 2014

11 July 2014 at 08:00 – Regulatory – Report – Q2

Interim report January-June 2014

Orexo Added to Russell Global Index

30 June 2014 at 08:30 – Regulatory

Orexo Added to Russell Global Index

Number of shares and votes in Orexo

30 May 2014 at 16:30 – Regulatory

Number of shares and votes in Orexo

Interim report January-March 2014

25 April 2014 at 08:00 – Regulatory – Report – Q1

Interim report January-March 2014

Report from Orexo AB’s annual general meeting, 15 April 2014

15 April 2014 at 19:00 – Regulatory – General Meeting

Report from Orexo AB’s annual general meeting, 15 April 2014

Number of shares and votes in Orexo

31 March 2014 at 16:30 – Regulatory

Number of shares and votes in Orexo

Orexo’s annual report for 2013 released

25 March 2014 at 13:18 – Regulatory – Report

Orexo’s annual report for 2013 released

Notice of Annual General Meeting of Orexo

14 March 2014 at 10:00 – Regulatory – General Meeting

Notice of Annual General Meeting of Orexo

Number of shares and votes in Orexo

31 January 2014 at 16:30 – Regulatory

Number of shares and votes in Orexo

Full year report January-December 2013

30 January 2014 at 08:00 – Regulatory – Report – Q4

Full year report January-December 2013

Orexo adjusts EBIT expectations for Q4, 2013

20 December 2013 at 08:45 – Regulatory

Orexo adjusts EBIT expectations for Q4, 2013

Letter to Orexo shareholders from Chairman Martin Nicklasson

19 December 2013 at 14:22 – Regulatory

Letter to Orexo shareholders from Chairman Martin Nicklasson

Orexo advances from Small to Mid Cap

19 December 2013 at 09:02 – Regulatory

Orexo advances from Small to Mid Cap

Orexo announces the launch of Abstral® in Japan

12 December 2013 at 09:30 – Regulatory

Orexo announces the launch of Abstral® in Japan

President and CEO

Nikolaj Sørensen

EVP & Chief Financial Officer

Fredrik Järrsten